Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: A preliminary report

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Yao, Kang ^a   Lu, Hao ^a   Huang, Rongchong ^a   Zhang, Shuning ^a   Hong, Xiaowu ^b   Shi, Hongyu ^a   Sun, Aijun ^a   Qian, Juying ^a   Zou, Yunzeng ^a   Ge, Junbo ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Atherosclerosis; dendritic cell; Fractalkine; Immune response; Unstable angina pectoristype 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CD86 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FRACTALKINE; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 12; ALPHA INTERFERON; BIOLOGICAL MARKER;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION COEFFICIENT; DENDRITIC CELL; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FUNCTIONAL STATUS; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL SIGNIFICANCE; UNSTABLE ANGINA PECTORIS; AGED; BLOOD; CASE CONTROL STUDY; CELL PROLIFERATION; COMORBIDITY; CORONARY ARTERY DISEASE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; T LYMPHOCYTE;

ADULT; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHEMOKINE CX3CL1; COMORBIDITY; CORONARY ARTERY DISEASE; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-12; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; T-LYMPHOCYTES;

EID: 79958063391     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-50     Document Type: Article

References (31)

1. Michael B. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-17. 10.1038/414813a, 11742414.
2. Burke AP, Kolodqie FD, Zieske A, Fowler DR, Weber DK, Farb A, Virmani R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Bio 2004, 24:1266-71.
3. Pajune P, Nieminen MS, Taskinen MR. Quantitative comparision of angiographic characteristics of coronary artery disease in patients with non-insulin depentdent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol 1997, 80:550-56. 10.1016/S0002-9149(97)00420-7, 9294980.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207, 9887164.
5. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edge sword. Nat Rev Immunol 2006, 6:508-19. 10.1038/nri1882, 16778830.
6. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews 2003, 24:278-301. 10.1210/er.2002-0010, 12788800.
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143. 10.1161/hc0902.104353, 11877368.
8. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001, 106:259-62. 10.1016/S0092-8674(01)00456-1, 11509173.
9. Bobryshev YV, Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovas Res 1995, 29:6892-6896.
10. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, Raaz D, Anger T, Amann T, Probst T, Ludwig J, Daniel WG, Garlichs CD. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004, 176:101-110. 10.1016/j.atherosclerosis.2004.04.027, 15306181.
11. Yilmaz A, Weber J, Cicha I, Stumpf C, Klein M, Raithel D, Daniel WG, Garlichs CD. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol 2006, 48:70-80. 10.1016/j.jacc.2006.01.078, 16814651.
12. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P, Tedqui A, Murphy PM, Mallat Z. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003, 107:1009-1016. 10.1161/01.CIR.0000057548.68243.42, 12600915.
13. Lesnik P, Haskell CA, Charo IF. Deceased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003, 111:333-340. 151849, 12569158.
14. Damas JK, Boullier A, Waehre T, Smith C, Sandberg WJ, Green S, Aukrust P, Quehenberger O. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 2005, 25:2567-72. 10.1161/01.ATV.0000190672.36490.7b, 16224053.
15. Apostolakis S, Krambovitis E, Vlata Z, Kochiadakis GE, Baritaki S, Spandidos DA. CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators. Thromb Res 2007, 121(3):387-95. 10.1016/j.thromres.2007.04.005, 17521710.
16. Ikejima H, Imanishi T, Tsujioka H, Kashiwagi M, Kuroi A, Tanimoto T. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circ J 2010, 74:337-345. 10.1253/circj.CJ-09-0484, 20019415.
17. Liu P, Yu YR, Spencer JA, Johnson AE, Vallanat CT, Fong AM, Patterson C, Patell DD. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol 2008, 28:243-250.
18. Shi HY, Ge JB, Fang WY, Yao K, Sun A, Huang R, Wang KQ, Zou YZ, Cao XT. Peripherial blood dendritic cell in men with coronary heart disease. Am J Cardiol 2007, 100:593-597. 10.1016/j.amjcard.2007.03.067, 17697812.
19. Ge J, Jia Q, Liang C, Huang D, Sun A, Wang K. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol 2005, 25:2157-2163. 10.1161/01.ATV.0000181744.58265.63, 16100036.
20. Bunn RC, Cockrell GE, Ou Y, Thrailkill KM, Lumpkin CK, Fowlkes JL. Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol 2010, 9:73. 10.1186/1475-2840-9-73, 2988002, 21054880.
21. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, Leboeuf RC, Hamerman JA, Sorg C, Kerkhoff C, Bornfeldt KE. S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation 2011, 123:1216-1226. 10.1161/CIRCULATIONAHA.110.985523, 21382888.
22. Qian J, Lu H, Yao K, Huang R, Sun A, Hao Y, Wang KQ, Zou YZ, Ge JB. The effect and mechanism of high concentration of insulin induced immune maturation of human monocyte-derived dendritic cells. Am J Cardiol 2007, 99(suppl8):93F-94F.
23. Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005, 26:1700-1704. 10.1093/eurheartj/ehi282, 15855191.
24. Bauriedel G, Jabs A, Skowasch D, Hutter R, Badimon JJ, Fuster V, Welsch U, Luderitz B. Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression with anti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol 2003, 42:930-938. 10.1016/S0735-1097(03)00828-3, 12957445.
25. Penna G, Vulcano M, Sozzani S, Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 2002, 63:1164-71. 10.1016/S0198-8859(02)00755-3, 12480260.
26. Alderman CJ, Bunyard PR, Chain BM, Foreman JC, Leake DS, Katz DR. Effects of oxidised low density lipoprotein on dendritic cells: a possible immuno-regulatory component of the atherogenic micro-environment. Cardiovasc Res 2002, 55:806-819. 10.1016/S0008-6363(02)00447-9, 12176130.
27. Angeli V, Llodra J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph G. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 2004, 21:561-574. 10.1016/j.immuni.2004.09.003, 15485633.
28. Rissoan MC, Soumelis V, Kadowaki N, Briere F, de Waal Malefyt R, Liu YJ. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186. 10.1126/science.283.5405.1183, 10024247.
29. Bobryshev YV. Dendritic cells and their involvement in atherosclerosis. Curr Opin Lipidol 2000, 11:511-517. 10.1097/00041433-200010000-00009, 11048894.
30. Santiago-Schwarz F, Divaris N, Carsons SE. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 1993, 82:3019-3028.
31. Reid CD, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colonystimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34 + progenitors in human bone marrow. J Immunol 1992, 149:2681-2688.